This study is in progress, not accepting new patients
Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Harpoon Therapeutics
- ID
- NCT03872206
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 200 study participants
- Last Updated